News
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...
Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.
When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...
The U.S. pays about three times more than other nations for drugs, and Trump's wide-reaching executive order directs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback